Vertex Ventures HC
Venture capitalSingapore · Seed–Growth · 6 people tracked
Investment thesis
Vertex Ventures HC invests in life science innovation, building a portfolio of healthcare companies developing transformative therapies and medical technologies. As part of Vertex's global network of venture capital funds—with affiliates in China, Israel, Japan, Southeast Asia, India and the US—the firm focuses on supporting portfolio companies through key growth and value-creation milestones, spanning clinical-stage therapeutic assets and medical technology products.
Source: firm website, verified Aug 7, 2026.
Team · 6 people
from public directoriesWhat they invest in
from 2 of 4 portfolio companiesBiotech ×2Deep Tech ×1Healthtech ×1Medical Devices ×1
HQs:United States×1
Investments · 4 tracked
founders shown can be your intro pathNeuspera develops an integrated sacral neuromodulation system for treating urinary urge incontinence, using a smart implanted neurostimulator paired with a wireless external battery.
BiotechHealthtechMedical DevicesSan Jose, US
Milton M. Morris(Executive Officer, Director)
Septerna develops oral small molecule drug candidates targeting G protein-coupled receptors (GPCRs) using its proprietary Native Complex Platform.
BiotechDeep Tech
Frequently asked questions
- What stage does Vertex Ventures HC invest at?
- Vertex Ventures HC invests at the Seed, Series A, Series B, Series C, Growth stages.
- What is Vertex Ventures HC's typical check size?
- Vertex Ventures HC typically writes checks of $500K – $10M.
- What sectors does Vertex Ventures HC focus on?
- Vertex Ventures HC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Vertex Ventures HC located?
- Vertex Ventures HC is headquartered in Singapore, SG.
Media · Podcasts & interviews
featuring the teamBiotech Trends & Innovations with Christine Brennan and Lori Hu, Vertex Ventures HC
Vertex · Lori Hu
Images
Co-investors · 10
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.
HOF Capital is a New York-based venture capital firm investing in companies transforming foundational industries through advanced software and AI.
RA Capital invests in public and private healthcare and life science companies developing pharmaceuticals, medical devices, and diagnostic tools. The firm operates as a crossover fund across multiple investment stages.
The National Science Foundation (NSF) is a U.S. federal government agency that funds research and education across science and engineering fields, supporting researchers, students, educators and organizations nationwide through grants.
Illuminate Ventures is an early-stage venture firm focused on B2B/enterprise software companies, typically serving as a startup's first institutional investor and leading Series Seed rounds.
Foothill Ventures is a technology-focused venture fund based in Los Altos, California, run by a team with founder and operator backgrounds. It makes early-stage investments in frontier technology, particularly infrastructure and AI applications.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
.jpeg)
Vida Ventures is a life sciences venture capital firm focused on transforming biomedical innovations into therapies that improve patients' lives.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
Firms observed investing alongside Vertex Ventures HC, from public investor directories. Shared companies are the overlap with Vertex Ventures HC's recorded portfolio.
Similar investors
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
Abingworth is a life science venture capital firm that backs early-stage biopharma and biotech companies, helping entrepreneurs translate scientific discoveries into new therapeutics.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.